The international journal of biochemistry & cell biology

ATP1B4 may control muscle loss in diabetes by affecting cell recycling through the PI3K/AKT/mTOR pathway

Updated

Abstract

ATP1B4 expression was upregulated in diabetic sarcopenia rats, suggesting its potential role in muscle metabolism.

  • Bioinformatic analysis identified ATP1B4 as a gene linked to muscle metabolism and enriched in pathways related to extracellular matrix.
  • In diabetic sarcopenia models, ATP1B4 expression coincided with reduced activity of the PI3K/AKT/mTOR signaling pathway and increased mitophagy markers.
  • Overexpression of ATP1B4 led to worsened hyperglycemia, muscle atrophy, collagen accumulation, and excessive glycogen storage.
  • Knocking down ATP1B4 reversed negative effects on muscle function and reduced pathological features associated with diabetes.
  • Activation of the PI3K/AKT/mTOR pathway improved muscle integrity and autophagy, but co-overexpression of ATP1B4 negated these benefits.
  • ATP1B4 appears to function as an upstream suppressor of the PI3K/AKT/mTOR pathway in diabetic sarcopenia.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free